Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIZE-HF: Improving Heart Failure Care in Hospitalized Patients
NCT00344513Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2002
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of carvedilol in heart failure (HF), sponsored by GSK. Started Dec 2002; status: completed.
02
Drugs
carvedilol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00344513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00344513.